[1]
TCHUMBURIDZE, T. et al. 2023. RISKS OF POLYPHARMACY IN THE TREATMENT OF HYPERTENSION. Experimental and Clinical Medicine Georgia. 4 (Nov. 2023), 48–52. DOI:https://doi.org/10.52340/jecm.2023.04.13.